Literature DB >> 32366400

Androgen-induced Epigenetic Profiles of Polycomb and Trithorax Genes in Prostate Cancer Cells.

Songping Wang1, Krishma Tailor1, Bernard Kwabi-Addo2.   

Abstract

BACKGROUND/AIM: Androgens are essential for the growth of most prostate cancers (PCa). As a result, androgen ablation is the mainstay of the treatment of PCa. Proteins of the polycomb and trithorax family are master epigenetic regulators of cell type specific gene expression including androgen receptor.
MATERIALS AND METHODS: We interrogated epigenetic changes of a 24-gene panel corresponding to polycomb and trithorax genes by PCR array and differential gene expression by quantitative real time-PCR on prostate cancer cell line (LNCaP) treated with the synthetic ligand R1881.
RESULTS: We observed the highest methylation for CBX2, PCGF6, PHC2, EZH2 and TRIM27 genes and the lowest methylation for CBX8 and PCGF2 (p<0.05), and a modest decrease in the expression of EZH2.
CONCLUSION: Differential methylation profiles of polycomb and trithorax genes may contribute to the dynamics of prostate carcinogenesis. Copyright
© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Polycomb and Trithorax genes; androgen stimulation; prostate cancer cells; quantitative RT-PCR

Mesh:

Substances:

Year:  2020        PMID: 32366400      PMCID: PMC8833844          DOI: 10.21873/anticanres.14226

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  33 in total

Review 1.  Epigenetic regulation of signaling pathways in cancer: role of the histone methyltransferase EZH2.

Authors:  Daisy P F Tsang; Alfred S L Cheng
Journal:  J Gastroenterol Hepatol       Date:  2011-01       Impact factor: 4.029

Review 2.  Steroid biosynthesis and prostate cancer.

Authors:  Nima Sharifi; Richard J Auchus
Journal:  Steroids       Date:  2012-04-05       Impact factor: 2.668

Review 3.  Androgen receptor rediscovered: the new biology and targeting the androgen receptor therapeutically.

Authors:  Charles J Ryan; Donald J Tindall
Journal:  J Clin Oncol       Date:  2011-08-22       Impact factor: 44.544

4.  The polycomb group protein EZH2 is involved in progression of prostate cancer.

Authors:  Sooryanarayana Varambally; Saravana M Dhanasekaran; Ming Zhou; Terrence R Barrette; Chandan Kumar-Sinha; Martin G Sanda; Debashis Ghosh; Kenneth J Pienta; Richard G A B Sewalt; Arie P Otte; Mark A Rubin; Arul M Chinnaiyan
Journal:  Nature       Date:  2002-10-10       Impact factor: 49.962

Review 5.  Stem cells and cancer; the polycomb connection.

Authors:  Merel E Valk-Lingbeek; Sophia W M Bruggeman; Maarten van Lohuizen
Journal:  Cell       Date:  2004-08-20       Impact factor: 41.582

Review 6.  Polycomb Group (PcG) Proteins and Human Cancers: Multifaceted Functions and Therapeutic Implications.

Authors:  Wei Wang; Jiang-Jiang Qin; Sukesh Voruganti; Subhasree Nag; Jianwei Zhou; Ruiwen Zhang
Journal:  Med Res Rev       Date:  2015-07-30       Impact factor: 12.944

Review 7.  Molecular regulation of androgen action in prostate cancer.

Authors:  Scott M Dehm; Donald J Tindall
Journal:  J Cell Biochem       Date:  2006-10-01       Impact factor: 4.429

8.  Identification of novel DNA-methylated genes that correlate with human prostate cancer and high-grade prostatic intraepithelial neoplasia.

Authors:  J M Devaney; S Wang; S Funda; J Long; D J Taghipour; R Tbaishat; P Furbert-Harris; M Ittmann; B Kwabi-Addo
Journal:  Prostate Cancer Prostatic Dis       Date:  2013-07-30       Impact factor: 5.554

Review 9.  Putting the brakes on continued androgen receptor signaling in castration-resistant prostate cancer.

Authors:  Andrew Eichholz; Roberta Ferraldeschi; Gerhardt Attard; Johann S de Bono
Journal:  Mol Cell Endocrinol       Date:  2011-10-01       Impact factor: 4.102

10.  Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator.

Authors:  Jung Kim; Yongik Lee; Xiaodong Lu; Bing Song; Ka-Wing Fong; Qi Cao; Jonathan D Licht; Jonathan C Zhao; Jindan Yu
Journal:  Cell Rep       Date:  2018-12-04       Impact factor: 9.423

View more
  2 in total

1.  Development and validation of a nomogram with an epigenetic signature for predicting survival in patients with lung adenocarcinoma.

Authors:  Jiao Wang; Li He; Yunliang Tang; Dan Li; Yuting Yang; Zhenguo Zeng
Journal:  Aging (Albany NY)       Date:  2020-11-18       Impact factor: 5.682

2.  hsa‑miR‑429 targets CBX8 to promote cell apoptosis in diffuse large B‑cell lymphoma.

Authors:  Yan Liang; Zhuo-Jun Yu; Min Liu; Hui-Min Liu; Jiang-Zhao Zhang; Tao Xiong; Yuan-Yan Tang; Zhi-Ping Huang
Journal:  Mol Med Rep       Date:  2021-10-15       Impact factor: 2.952

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.